Sova Health, India’s first full-stack gut health company has introduced two advanced diagnostic tools the Gut Microbiome Test (GMT) and the Food Intolerance Test (FIT) designed to deliver personalized science-backed digestive care. Leveraging India’s largest proprietary gut microbiome database built from whole genome sequencing of over 35,000 samples this launch marks a strategic move to transition gut health management from symptom-based methods to data-driven solutions.

Whole Genome Sequencing Enables Precision in Digestive Diagnostics
The newly launched diagnostics are powered by India’s largest proprietary gut microbiome database developed through whole genome sequencing of over 35,000 samples.

The Gut Microbiome Test evaluates the composition of gut bacteria short-chain fatty acid (SCFA) levels and essential metabolic markers. In parallel the Food Intolerance Test identifies sensitivities potentially linked to chronic digestive problems.

Combined these tools aim to deliver more accurate and actionable insights than traditional diagnostic methods.

Max Kushnir Co-founder and Chief Scientific Officer at Sova Health emphasized the company’s mission to integrate genomic technology with real-world healthcare applications.

Through genomic sequencing we’re delivering an unprecedented level of accuracy and personalization in gut health solutions he stated. These tests enable individuals to take control of their digestive wellness with customized evidence-based insights.

Integrated Gut Health Ecosystem & Commitment to Data Privacy 
Sova Health incorporates these diagnostics into a comprehensive ecosystem featuring personalized nutrition plans and custom probiotic formulations including its flagship product SovaX introduced in October 2024.

SovaX is promoted as Asia’s first personalized probiotic supplement crafted based on an individual’s unique gut microbiome profile.

Ensuring data privacy is central to Sova Health’s approach. The company adheres to Indian Council of Medical Research (ICMR) guidelines and allows users to request deletion of their data at any time.

Tanveer Singh Co-founder of Sova Health emphasized the company’s dedication to making evidence-based digestive care more accessible.

Our mission is to move beyond one-size-fits-all solutions. With our latest diagnostics and products we’re focused on delivering truly personalized care he said.

Early adoption of the Gut Microbiome Test (GMT) and Food Intolerance Test (FIT) has already shown promising results with users experiencing reduced symptoms and decreased reliance on traditional treatments for chronic digestive conditions.

Looking forward Sova Health plans to broaden its diagnostic portfolio to include skin and oral microbiome testing along with comprehensive metabolic marker analysis advancing its vision of a holistic personalized health platform.

Source: https://www.digitalhealthnews.com/sova-health-launches-gut-microbiome-food-intolerance-tests-to-advance-personalised-digestive-care